Ventilator-associated pneumonia
(Redirected from VAP)
Urachal fistula is a rare condition that occurs when the urachus, a tube that connects the bladder to the umbilical cord in fetal development, fails to close after birth. This can lead to a variety of symptoms and complications, including infection and abdominal pain.
Symptoms[edit | edit source]
The most common symptoms of a urachal fistula include:
- Abdominal pain
- Fever
- Urinary tract infection
- Discharge from the umbilicus
Causes[edit | edit source]
The exact cause of a urachal fistula is unknown, but it is believed to be due to a failure of the urachus to close completely after birth. This can result in a connection between the bladder and the umbilicus, allowing urine to pass through and potentially leading to infection.
Diagnosis[edit | edit source]
Diagnosis of a urachal fistula can be challenging due to its rarity and the nonspecific nature of its symptoms. However, several diagnostic tests can be used, including:
Treatment[edit | edit source]
Treatment for a urachal fistula typically involves surgery to remove the fistula and any associated abscesses or tumors. Antibiotics may also be prescribed to treat any underlying infections.
Prognosis[edit | edit source]
With appropriate treatment, the prognosis for individuals with a urachal fistula is generally good. However, complications can occur, including recurrent infections and the development of urachal carcinoma, a rare form of bladder cancer.
See also[edit | edit source]
References[edit | edit source]
Ventilator-associated pneumonia Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD